After the 2008 deli-meat listeriosis outbreak, Health Canada started a review of its policy on Listeria monocytogenes in ready-to-eat foods to update the policy with the latest science available. The revised policy incorporates the recommendations in the Report of the Independent Investigator into the 2008 Listeriosis Outbreak. The DepartmentFootnote 1 has currently completed its update of the 2004 policy on Listeria monocytogenes in RTE foods, in view of enhancing the control of Listeria in high-risk foods.
The purpose of this policy is to provide guidance regarding industry verification and control, as well as regulatory oversight and compliance activities of RTE foods with respect to their potential to support the growth of Listeria monocytogenes. More specifically, the revised policy differs from the 2004 version in that:
Note: Bureau of Microbial Hazards: lead; Bureau of Food Policy and Science Integration, Bureau of Chemical Safety, Food Directorate, Health Products and Food Branch, Health Canada along with the Canadian Food Inspection Agency (i.e., Agri-Food and Meat Sector, Operation Strategy and Delivery, Food Safety and Consumer Protection and Laboratory Operation) and the Public Health Agency of Canada (i.e., Surveillance Division), have been involved in updating the policy document.
On March 22, 2010, the proposed "Policy on Listeria monocytogenes in ready-to-eat (RTE) foods" was posted on the Health Canada website in order to obtain comments from the large stakeholder community. At the same time, Health Canada's Bureau of Microbial Hazards (BMH), Food Directorate sent e-mails to targeted stakeholder groups requesting their input on the proposed policy document. Comments were accepted until 12:00 a.m. EDT on May 3, 2010.
On March 29, 2010 the Bureau of Microbial Hazards, Food Directorate, Health Canada, participated in a question-and-answer session on the Health Canada's proposed revised policy on Listeria monocytogenes in RTE foods. This session was to notify consumer's associations of the public consultation and to answer any questions they may have had concerning this subject.
Health Canada received input from various stakeholders representing governments, industry, academia and professional organizations, including:
Governments:
Industry:
Academia:
Professional organizations:
Stakeholders generally supported the proposed policy on Listeria monocytogenes in RTE foods and noted that the draft is aligned with the International Codex Alimentarius Commission standards.
Key issues that were identified by stakeholders during the comment period are highlighted below.
How does this policy apply to the retail food sector (e.g., retail establishments that slice ready-to-eat meats for consumers, etc.)?
This policy does not address the foodservice or retail establishments. It is the intention of the Listeria policy to provide guidance to RTE food processors on how to address L. monocytogenes in the environment of processing establishments. Specific guidance for foodservice and retail establishments is not provided in this policy, but will be addressed in separate documents being drafted jointly with industry.
How does one define RTE foods that are "targeted to high risk populations"?
RTE foods that are intended to be produced for consumption by individuals who are known to be in the high-risk category (i.e., final distribution of such ready-to-eat products is known to be targeted specifically to pregnant women, elderly and/or immunocompromised individuals) should receive the highest priority for industry verification and control, as well as regulatory oversight and compliance activities.
If you know that a RTE product which initially falls within Category 2 is intended to be produced for a high-risk population, would it be tested as per Category 1 (i.e., presence/absence)? If not, what levels would make it a Health Risk 1, i.e., > 100 CFU/g or ≤ 100 CFU/g?
If counts are > 100 CFU/g, the product(s) would be considered a Health Risk 1 situation automatically. If counts ≤ 100 CFU/g are detected, a Health Risk Assessment may be requested which may lead to a Health Risk 1 concern.
Under which circumstances would a Health Risk Assessment be requested/performed, and how does one ensure consistency?
The goal of this policy is to provide general guidance regarding industry verification and control, as well as regulatory oversight and compliance activities of RTE foods with respect to their potential to support the growth of L. monocytogenes. Specifics will be left to the discretion of the regulatory authority.
Could any Listeria spp. or L. monocytogenes specific method be used for analysis?
Analysis of "food contact surfaces/non-food contact surfaces/end-products" for the presence of "Listeria spp./L. monocytogenes" should be conducted using any method published in the Health Canada's Compendium of Analytical Methods for "Listeria spp./L. monocytogenes" in which the "application" section is appropriate for the intended purpose (e.g., MFHPB methods and MFLP methods).
What is the recommended testing frequency for RTE products based on their categories?
The purpose of this policy is to provide general guidance. Specifics will be left to the discretion of the regulatory program (to be determined by each program).
How many food contact surface and non-food contact surface sites should be analyzed to be in line with the Listeria policy?
The number of meaningful food contact surface and non-food contact surface sampling sites (preferably 10) selected on each processing line/in the plant should depend on the complexity of the line(s)/plant, respectively. If more than 10 food contact surface/non-food contact surface sites are selected, a compositing protocol should be developed and validated. The number of swabs and enrichment protocol may vary according to the processing conditions. Figures 1, 2 and 3 should be followed accordingly.
What actions should be taken when a food contact surface is positive for L. monocytogenes versus Listeria spp.?
If a food contact surface is found positive for Listeria spp., Figures 1 and 2 (depending on the type of ready-to-eat food being produced) should be followed. If any food contact surface is found positive for L. monocytogenes, end-product testing for L. monocytogenes should be performed.
It may appear that no action is required after the first Listeria spp. positive result in the environment, meaning that no follow-up in the end-product is required, and hence, allowing a contaminated product to be in the Canadian food supply. How is this protecting the health of Canadians?
In Step A of Figures 1 and 2, the recommendation is to test for Listeria spp. on food contact surfaces. Results from this test would not definitely indicate if L. monocytogenes is present or not in the food, but provide an indication that further testing and corrective actions are required, as per Figure 1 or 2. Guidance in Figures 1 and 2 is reflective of the risk the RTE food may pose to consumers if contaminated with Listeria. Our goal is to encourage companies to perform aggressive environmental sampling on a regular basis and perform trend analysis on their results to detect problems that need corrective action.
Can high-pressure processed food be considered under Category 2B?
No, high pressure processed food will not automatically be considered to fall under Category 2B. However, other criteria (e.g., process, packaging, outbreak data) could have an impact on the level of priority for oversight assigned to the RTE food products.
The policy outlines the categorization of RTE products based on scientific information. What might constitute acceptable validation data? Could the use of growth models be acceptable in some circumstances as supportive data? Could literature reviews be utilized, etc?
RTE foods in which the growth of L. monocytogenes will not occur or in which limited growth of L. monocytogenes to levels not greater than 100 CFU/g can occur, should be determined based on scientific data. This can be demonstrated, for example, by challenge tests, information from the scientific literature, validated predictive microbiological modeling complemented with other data sources, Health Risk Assessments, or a combination of these. The measurement error of the validation method should also be taken into consideration.
How is a "lot" being defined in this policy document?
"A lot consists of all of the same product type processed on a given line, between two complete sanitation cycles, but not exceeding one day's production. When testing this lot, the 5 sample units submitted for analysis must be representative of these products and production conditions".
Implicated RTE products:
"As a minimum, all the products processed on the same line (i.e., using the same equipment) as the tested products are considered implicated when a tested lot has an unsatisfactory result. It should be noted that results from root cause analysis may also trigger the need to include additional products as part of the implicated products".
Line:
"A number of pieces of equipment (e.g., slicers, tables, conveyors, packaging or filling machines) used in series in the post-lethality environment, as applicable, to prepare RTE foods for final packaging".
Are there any food exemptions to this policy?
Yes, for example, the following foods would be exempt from the provisions of the Listeria policy: